A drug administration controller has a sensor that generates a sensor signal to a physiological measurement device, which measures a physiological parameter in response. A control output responsive to the physiological parameter or a metric derived from the physiological parameter causes a drug administration device to affect a treatment of a person, such as by initiating, pausing, halting or adjusting a dosage of drugs administered to the person.

A fluid delivery system provides fluid, such as supplement oxygen, to a patient in response to inhalation. The fluid delivery system includes a valve assembly that is triggered by sensing onset of inspiration by measuring a change in temperature or fluid flow of air flow in a nasal or oral cannula, mask or helmet.

An example aerosol delivery device includes a mouthpiece having an airflow outlet, and an airflow passage extending between an airflow inlet and the airflow outlet. The example aerosol delivery device further includes a housing configured to receive a cartridge that includes an aerosolizable substance and a vapor element configured to heat the aerosolizable substance, and an internal power source configured to provide electrical power. The example aerosol delivery device further includes a controller coupled to the internal power source to receive a portion of the electrical power and configured to, when the cartridge is installed at the housing, cause the vapor element of the cartridge to heat the aerosolizable substance to release an aerosol into the airflow passage during an inhalation through the airflow outlet, and a connector configured to receive power from an external source to recharge the internal power source.

A process (10), with a computer program, a device (30) and a ventilation system (40) detect a leak in a patient gas module, which suctions and analyzes a continuous sample gas stream from a ventilated patient (20), in a ventilation system for ventilating a patient (20). The process includes a determination (12) of a first time curve of a carbon dioxide concentration in a breathing gas mixture of the patient (20) and the determination (14) of a second time curve of a concentration of another gas in the breathing gas mixture, which gas is different from carbon dioxide. The process (10) further includes a determination (16) of a statistical similarity indicator between the first time curve and the second time curve and the detection (18) of the leak based on the similarity indicator.

The invention relates to an inhalable gaseous medicament containing argon gas for use in combination with a mechanical thrombectomy for treating, reducing or resorbing brain lesions subsequent to an ischaemic stroke in an individual. Preferably, the proportion by volume of argon is between 30 and 79%. The mechanical thrombectomy can be accompanied by a drug-based thrombolysis to dissolve the clot and to thin the blood of the patient.

This invention provides ventilators that provide superior air-oxygen mixing and gas delivery. The ventilators that supply a gas mixture to the lungs of a subject. The gas mixture comprises a first gas (e.g. oxygen) and a second gas (e.g. ambient air). The ventilators comprise a first gas inlet, a second gas inlet, flow modulator of the first gas, a flow modulator of the second gas, a junction configured to mix the first gas and the second gas, a patient interface configured to deliver the gas mixture to a subject, a pressure sensor, a plurality of flow sensors comprising at least a first flow sensor and a second flow sensor, and at least one controller configured for obtaining data from the pressure sensor and flow sensors and controlling the flow modulators to provide a gas mixture having a target pressure and a target oxygen content.

An asymmetric hydrophobic polyolefin hollow fiber membrane includes a support layer and a separation layer, the separation layer including an outer surface, the outer surface including a quantity of first pores with a certain pore size; presence of the first pores facilitates an anesthetic gas such as sevoflurane and remifentanil to permeate through the hollow fiber membrane into the human blood, allowing for the patient to maintain sedated throughout a surgical process; meanwhile, the first pores facilitate reduction of dosage of the anesthetic in the surgery, thereby reducing surgical costs and avoid overdosage of the anesthetic causing secondary impairment to the patient; in addition, the hollow fiber membrane offers a long plasma permeation duration, a high tensile strength and a high elongation at break to satisfy application needs, particularly suitable for human blood oxygenation including anesthetic gas and the gas-liquid separation areas.

Methods and systems and related particles and compositions that can be used to deliver a biologically active cargo such as a drug to a cornea of an individual, the delivery performed in a rapid, nonsurgical, and/or controllable fashion are described. Particularly, a method is described for controlled ballistic delivery of a cargo in a microparticle to the cornea of an individual, including a biologically active cargo.

A patient airway dome including an adjustable frame having a hinge such that the hinge allows the frame to adjust between an erected position to create an airway dome and a collapsed position that allows the frame to lay flat, a dome covering located over the retractable frame, a suction port which is connected to a conventional device in order to provide negative pressure to patient airway dome, and an arm access assembly operatively connected to the dome covering, wherein the arm access assembly includes an opening in the dome covering and a closure assembly located adjacent to the opening.

A system (1000) feeds substances to a patient (30) with a ventilation of the patient and with an oxygenation of the patient. The system (1000) has at least one ventilation system (1), a sedation by inhalation system (17) with a dispensing system (7), an oxygenation system (2), a breathing gas dispensing path (3), a purge gas dispensing path (4), a breathing gas connection system (5), a connection element (25) located adjacent to the patient, an oxygenation connection system (6) and a switching unit (8). The switching unit (8) is configured to distribute and to split a quantity of an inhalable substance dispensed into a gas mixture by means of the dispensing system (7) between the connection element (25) located adjacent to the patient and the oxygenation system (2). At least one control unit (9, 10, 11, 12) is configured to control the switching unit (8) and/or the system (1000).